NCT00296803View on ClinicalTrials.gov

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

August 31, 2006

Conditions
Metabolic Syndrome x
Interventions
DRUG

clopidogrel

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY